p73: Structure and function

Alteration of the p53 tumor suppressor gene is a common, if not general, observation in human malignant tumors. p73 Is a novel member of the p53 family at chromosome 1p36.3, at which locus frequent defects are seen in many tumors including neuroblastoma. Besides structural similarities, the fact that p73 functions in the regulation of the cell cycle and apoptosis promotes the expansion of the research field concerning p53‐associated tumor progression. In this paper, we review the structure and function of p73 as well as the mutational status in various human tumors. In addition, possibilities for new therapeutic applications with p73 for cancer cell control are discussed.

[1]  A. Yang,et al.  p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours , 2000, Nature.

[2]  Rogier Versteeg,et al.  Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N–myc amplification , 1993, Nature Genetics.

[3]  W. Kaelin,et al.  p73 is a human p53-related protein that can induce apoptosis , 1997, Nature.

[4]  K. Vousden,et al.  Mdm2 binds p73 alpha without targeting degradation. , 1999, Oncogene.

[5]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[6]  M. Oren.  Lonely No More: p53 Finds Its Kin in a Tumor Suppressor Haven , 1997, Cell.

[7]  K. Vousden,et al.  Mdm2 binds p73α without targeting degradation , 1999, Oncogene.

[8]  A. Nakagawara,et al.  Mutational analysis of the p73 gene localized at chromosome 1p36.3 in colorectal carcinomas. , 1998, International journal of oncology.

[9]  C. Bartram,et al.  Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation. , 1999, Blood.

[10]  P. Kleihues,et al.  Tumors associated with p53 germline mutations: a synopsis of 91 families. , 1997, The American journal of pathology.

[11]  Chikashi Ishioka,et al.  Cloning and functional analysis of human p51, which structurally and functionally resembles p53 , 1998, Nature Medicine.

[12]  K. Kinzler,et al.  Oncogenic forms of p53 inhibit p53-regulated gene expression. , 1992, Science.

[13]  W. Kaelin.  The emerging p53 gene family. , 1999, Journal of the National Cancer Institute.

[14]  F. McKeon,et al.  p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent , 1999, Oncogene.

[15]  N. Nomura,et al.  p73, a geme related to p53, is not mutated in esophageal carcinomas , 1998, International journal of cancer.

[16]  M. Schwab,et al.  Genomic instability in Ip and human malignancies , 1996, Genes, chromosomes & cancer.

[17]  R. Agami,et al.  Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis. , 1999, Nature.

[18]  C. Arrowsmith,et al.  Solution structure of a conserved C‐terminal domain of p73 with structural homology to the SAM domain , 1999, The EMBO journal.

[19]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[20]  A. Nakagawara,et al.  Identification of a transactivation activity in the COOH-terminal region of p73 which is impaired in the naturally occurring mutants found in human neuroblastomas. , 1999, Cancer research.

[21]  Yohko Nakamura,et al.  Mutational analysis of the p73 Gene in human breast cancers , 1999, International journal of cancer.

[22]  Jijie Gu,et al.  p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage , 1999, Nature.

[23]  J. Roth,et al.  Inactivation of the p53-homologue p73 by the mdm2-oncoprotein , 1999, Oncogene.

[24]  A. Yang,et al.  Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers , 1997, Cell.

[25]  A. Nakagawara,et al.  Absence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma , 1999, British Journal of Cancer.

[26]  A. Nakagawara,et al.  Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma. , 1998, Cancer Research.

[27]  Reuven Agami,et al.  Interaction of c-Abl and p73α and their collaboration to induce apoptosis , 1999, Nature.

[28]  S. Chi,et al.  Elevated and biallelic expression of p73 is associated withprogression of human bladder cancer. , 1999, Cancer research.

[29]  L. Hartwell,et al.  The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. , 1988, Science.

[30]  Makoto Hijikata,et al.  New p73 variants with altered C-terminal structures have varied transcriptional activities , 1999, Oncogene.

[31]  J. Roth,et al.  Inactivation of p53 but Not p73 by Adenovirus Type 5 E1B 55-Kilodalton and E4 34-Kilodalton Oncoproteins , 1998, Journal of Virology.

[32]  J. Roth,et al.  The large T antigen of simian virus 40 binds and inactivates p53 but not p73. , 1998, The Journal of general virology.

[33]  K. Kinzler,et al.  A model for p53-induced apoptosis , 1997, Nature.

[34]  T. Davison,et al.  p73 and p63 Are Homotetramers Capable of Weak Heterotypic Interactions with Each Other but Not with p53* , 1999, The Journal of Biological Chemistry.